Anti-MAG paraproteinemic demyelinating polyneuropathy: A clinical, biological, electrophysiological and anatomopathological descriptive study of a 13-patients' cohort;Les polyneuropathies avec IgM monoclonale anti-MAG : étude descriptive clinique, biologique, électrophysiologique et anatomopathologique d'une cohorte de 13 patients

Revue Neurologique

Volumn 165, Issue 12, 2009, Pages 1071-1079

  Launay, M ^a   Delmont, E ^a   Benaim, C ^a   Sacconi, S ^a   Butori, C ^b   Desnuelle, C ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^b PASTEUR HOSPITAL   (France)

Author keywords

Anti MAG antibodies; Anti MAG polyneuropathy; Electroneuromyogram; ONLS

Indexed keywords

IMMUNOGLOBULIN M; MYELIN;

ADULT; AGED; ARTICLE; ATAXIA; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATING NEUROPATHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ELECTROPHYSIOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPESTHESIA; LIMB WEAKNESS; MALE; NERVE BIOPSY; NONHODGKIN LYMPHOMA; PARAPROTEINEMIA; PARESTHESIA; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; DEMYELINATING DISEASES; FEMALE; GAIT ATAXIA; HUMANS; IMMUNOGLOBULIN M; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEURAL CONDUCTION; PARAPROTEINEMIAS; PARESTHESIA; REACTION TIME;

EID: 71549148373     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurol.2009.04.008     Document Type: Article

References (30)

1. Antoine J.C., Steck A., and Michel D. Neuropathie périphérique avec atteinte motrice prédominante associée à une gammapathie IgM monoclonale anti-MAG. Rev Neurol (Paris) 149 (1993) 496-499
2. Attarian S., Azulay J.P., Boucraut J., Escande N., and Pouget J. Terminal latency index and modified F ratio in distinction of chronic demyelinating neuropathies. Clin Neurophysiol 112 (2001) 457-463
3. Bain P.G., Britton T.C., Jenkins I.H., Thompson P.D., Rothwell J.C., Thomas P.K., et al. Tremor associated with benigne IgM paraproteinaemic neuropathy. Brain 119 (1996) 789-799
4. Capasso M., Torrieri F., Di Muzio A., De Angelis M.V., Lugaresi A., and Uncini A. Can electrophysiology differentiate polyneuropathy with anti-MAG/SGPG antibodies from chronic inflammatory demyelinating polyneuropathy. Clin Neurophysiol 113 (2002) 346-353
5. Caudie C., Kaygisiz F., Jaquet P., Petiot P., Gonnaud P.M., Antoine J.C., et al. Diagnostic value of autoantibodies to MAG by Elisa Bühlmann in 117 immune-mediated peripheral neuropathies associated with monoclonal IgM to SGPG/SGLPG. Ann Biol Clin (Paris) 64 (2006) 353-359
6. Chassande B., Léger J.M., Ben Younes-Chennoufi A., Bengoufa D., Maisonobe T., Bouche P., et al. Peripheral neuropathy associated with IgM monoclonal gammapathy: correlations between M-protein antibody activity and clinical/electrophysiological features in 40 cases. Muscle Nerve 21 (1998) 55-62
7. Ellie E., Vital A., Steck A.J., Boiron J.M., Vital C., and Julien J. Neuropathy associated with "benign" anti-myelin-associated glycoprotein IgM gammapathy: clinical, immunological, neurophysiological pathological findings and response to treatment in 33 cases. J Neurol 243 (1996) 34-43
8. Gondim F.A.A., De Souza E.A., Latov N., Sander H.W., Chin R.L., and Brannagan T.H. Anti-MAG/SGPG associated neuropathy does not commonly cause distal nerve temporal dispersion. J Neurol Neurosurg Psychiatry 78 (2007) 902-904
9. Graham R.C., and Hughes R.A. A modified peripheral neuropathy scale: the Overall Neuropathy Limitations Scale. J Neurol Neurosurg Psychiatry 77 (2006) 899-900
10. Hughes R.A., Bouche P., Cornblath D., Evers E., Hadden R.D., Hahn A., et al. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Europ J Neurol 13 (2006) 326-332
11. Isoardo G., Migliaretti G., Ciaramitaro P., Rota E., Poglio F., Tavvella A., et al. Differential diagnosis of chronic dysimmune demyelinating polyneuropathies with and without anti-MAG antibodies. Muscle Nerve 31 (2005) 52-58
12. Jaskowski T.D., Martins T.B., Litwin C.M., and Hill H.R. Immunoglobulin (Ig) M antibody against myelin-associated glycoprotein (MAG): a comparison of methods. J Clin Lab Anal 18 (2004) 247-250
13. Kaku D.A., England J.D., and Summer A.J. Distal accentuation of conduction slowing in polyneuropathy associated with antibodies to myelin-associated glycoprotein and sulphated glucuronyl-paragloboside. Brain 117 (1994) 941-947
14. Levine T.D., and Pestronk A. IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using rituximab. Neurology 52 (1999) 1701-1704
15. Lupu V.D., Mora C.A., Dambrosia J., Meer J., Dalakas M., and Floeter M.K. Terminal latency index in neuropathy with antibodies against myelin-associated glycoproteins. Muscle Nerve 35 (2007) 196-202
16. Maisonobe T., Chassande B., Verin M., Jouni M., Leger J.M., and Bouche P. Chronic dysimmune demyelinating polyneuropathy: a clinical and electrophysiological study of 93 patients. J Neurol Neurosurg Psychiatry 61 (1996) 39-42
17. Merkies I.S., Scmitz P.I., Van de meché F.G., and Van Doorn P.A. Psychometric evaluation of new sensory scale in immune-mediated polyneuropathies. Neurology 54 (2000) 943-949
18. Nobile-Orazio E., Manfredini E., Carpo M., Meucci N., Monaco S., Ferrari S., et al. Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammapathy. Ann Neurol 36 (1994) 416-424
19. Nobile-Orazio E. Neuropathies associated with anti-MAG antibodies and IgMmonoclonal gammapathies. In: Latov Wokke J.H.J., and Kelly J.J. (Eds). Immunological and infectious diseases of the peripheral nerves (1998), Cambridge University Press, Cambridge 168-189
20. Nobile-Orazio E., Meucci N., Baldini L., Di Troia A., and Scarlato G. Long-term prognosis of neuropathy associated with anti-MAG M-proteins and its relationship to immune therapies. Brain 123 (2000) 710-717
21. Notermans N.C., Franssen H., Eurlings M., Van der Graaf Y., and Wokke J.H. Diagnostic criteria for demyelinating polyneuropathy associated with monoclonal gammapathy. Muscle Nerve 23 (2000) 73-79
22. Radziwill A., Steck A.J., Renaud S., and Fuhr P. Distal motor latency and residual latency as sensitive markers of anti-MAG polyneuropathie. J Neurol 250 (2003) 962-966
23. Renaud S., Gregor M., Fuhr P., Schweikert K., Lorenz D., Daniels C., et al. Rituximab in the treatment of polyneuropathy associated with anti-MAG antibodies. Muscle Nerve 27 (2003) 611-615
24. Smith I.S., Kahn S.N., Lacey B.W., King R.H., Eames R.A., Whybrew D.J., et al. Chronic demyelinating neuropathy associated with benign IgM paraproteinaemia. Brain 106 (1983) 169-195
25. Steck A.J., Meier C., Vandevelde M., and Regli F. Polyneuropathies et gammapathies: une forme avec antiglycoprotéine MAG. Rev Neurol (Paris) 140 (1984) 28-36
26. Steck A.J., and Kuntzer T. Dysglobulinémies IgM et complications neurologiques. Rev Neurol (Paris) 158 (2002) 971-978
27. Thaisetthawatkul P., Logigian E.L., and Herrmann D.N. Dispersion of the distal compound muscle action potential as a diagnostic criterion for chronic inflammatory demylinating polyneuropathy. Neurology 59 (2002) 1526-1532
28. Trojaborg W., Hays A.P., Vandeberg L., Younger D.S., and Latov N. Motor conduction parameters in neuropathies associated with antibodies with anti-MAG antibodies and other types of demyelinating and axonal neuropathies. Muscle Nerve 18 (1995) 730-735
29. Van den Berg L.H., Hays A.P., Nobile-Orazio E., Kinsella L.J., Manfredini E., Corbo M., et al. Anti-MAG and anti-SGPG antibodies in neuropathy. Muscle Nerve 19 (1996) 637-643
30. Vital A., Vital C., Julien J., Baquey A., and Steck A.J. Polyneuropathy associated with IgM monoclonal gammopathy. Immunological and pathological study in 31 patients. Acta Neuropathol (Berl) 79 (1989) 160-167